Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.

Ariën KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, Arts EJ.

J Virol. 2005 Jul;79(14):8979-90.

3.

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.

Bailey J, Blankson JN, Wind-Rotolo M, Siliciano RF.

Curr Opin Immunol. 2004 Aug;16(4):470-6. Review.

PMID:
15245741
4.
5.

Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission.

Wu L, Martin TD, Carrington M, KewalRamani VN.

Virology. 2004 Jan 5;318(1):17-23.

6.

Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.

Trkola A, Kuster H, Leemann C, Ruprecht C, Joos B, Telenti A, Hirschel B, Weber R, Bonhoeffer S, Günthard HF; Swiss HIV Cohot Study..

J Virol. 2003 Dec;77(24):13146-55.

7.

Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.

Rangel HR, Weber J, Chakraborty B, Gutierrez A, Marotta ML, Mirza M, Kiser P, Martinez MA, Este JA, Quiñones-Mateu ME.

J Virol. 2003 Aug;77(16):9069-73.

8.

A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.

Weber J, Rangel HR, Chakraborty B, Tadele M, Martinez MA, Martinez-Picado J, Marotta ML, Mirza M, Ruiz L, Clotet B, Wrin T, Petropoulos CJ, Quiñones-Mateu ME.

J Gen Virol. 2003 Aug;84(Pt 8):2217-28.

PMID:
12867654
10.
11.

Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.

Tuttle DL, Anders CB, Aquino-De Jesus MJ, Poole PP, Lamers SL, Briggs DR, Pomeroy SM, Alexander L, Peden KW, Andiman WA, Sleasman JW, Goodenow MM.

AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):353-62.

PMID:
11897037
12.

Estimating relative fitness in viral competition experiments.

Marée AF, Keulen W, Boucher CA, De Boer RJ.

J Virol. 2000 Dec;74(23):11067-72.

13.
14.
15.

A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.

Quiñones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, Vanham G, van Der Groen G, Colebunders RL, Arts EJ.

J Virol. 2000 Oct;74(19):9222-33.

16.

Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Schramm B, Penn ML, Speck RF, Chan SY, De Clercq E, Schols D, Connor RI, Goldsmith MA.

J Virol. 2000 Jan;74(1):184-92.

17.

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J.

Nat Med. 1999 May;5(5):535-41.

PMID:
10229230
18.
19.

Evolution of a simian immunodeficiency virus pathogen.

Edmonson P, Murphey-Corb M, Martin LN, Delahunty C, Heeney J, Kornfeld H, Donahue PR, Learn GH, Hood L, Mullins JI.

J Virol. 1998 Jan;72(1):405-14.

Supplemental Content

Support Center